Entity
TNF-alpha
--
G010329
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m93309
10
infinite
0
TRANSFAC | G010329 |
--
STATs
--
MO000016656
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1633
10
infinite
0
TRANSPATH | MO000016656 |
--
IL-4Ralpha
--
MO000017058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1951
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000017058 |
--
IL-4:IL-4Ralpha
--
MO000034134
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12691
10
infinite
0
TRANSPATH | MO000034134 |
--
IL-13Ralpha1
--
MO000045621
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m23256
10
infinite
0
InterPro | IPR003532 |
TRANSPATH | MO000045621 |
--
IL-13Ralpha2
--
MO000045622
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m23257
10
infinite
0
InterPro | IPR003532 |
TRANSPATH | MO000045622 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:TLR4
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m11
0
infinite
0
--
IL-2Rgamma:IL-2Rbeta
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
t-PA
--
e13
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m13
0
infinite
0
--
csml-variable:Double
m14
0
infinite
0
--
PGE2
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
IL-13:IL-13Ralpha1
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1:STAT6
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0
infinite
0
--
IL-4:IL-4Ralpha:IL-13Ralpha1
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m21
0
infinite
0
--
Il-13:IL-13Ralpha2
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m22
0
infinite
0
--
IL-13:IL-13Ralpha1:IL-4Ralpha:JAK1
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m24
0
infinite
0
--
IFNgammaR
--
e25
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m25
0
infinite
0
--
IFNgamma:receptor
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m26
0
infinite
0
--
GM-CSF:GM-CSFR
--
e27
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m27
0
infinite
0
--
IL-10:IL-10R
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m28
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IL-12
--
e30
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m30
0
infinite
0
--
IL-4{mutant}:IL-4Ralpha
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m33
10
infinite
0
TRANSPATH | MO000034134 |
--
Neutralizing antibiody
--
e34
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IL-2Rgamma
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
IL4:IL-4Ralpha:IL-2Rgamma
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 10534111 LPS binds its receptor TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m23256*m836*0.1
nodelay
--
0
PMID: 10534111, 8910586, 9013879 The IL-13Ra1 chain has weak IL-13 binding capacity on its own but binds IL-13 strongly on complexing with the IL-4Ra chain [26, 27].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m17*m1951*0.1
nodelay
--
0
PMID: 10534111, 8910586, 9013879 The IL-13Ra1 chain has weak IL-13 binding capacity on its own but binds IL-13 strongly on complexing with the IL-4Ra chain [26, 27].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c35 : 1
m18*0.1
nodelay
--
0
PMID: 10534111 For IL-13, the second bound receptor chain (IL-4Ra) functions to recruit JAK1 to the receptor complex, and to provide a docking site for STAT6 on its intracellular domain and thus provides a mechanism by which the biological effects of IL-4 and IL-13 on monocytes are very similar.
p13
p13
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m20*m1368*0.1
nodelay
--
0
PMID: 10534111 For IL-13, the second bound receptor chain (IL-4Ra) functions to recruit JAK1 to the receptor complex, and to provide a docking site for STAT6 on its intracellular domain and thus provides a mechanism by which the biological effects of IL-4 and IL-13 on monocytes are very similar.
p14
p14
cso30:i:ME_Dimerization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m12691*m23256*0.1
nodelay
--
0
PMID: 10534111, 9573026 There is strong evidence particularly on non-hematopoietic cells that the IL-4Ra chain on binding to IL-4 can heterodimerize with the IL-13Ra1 chain forming the type II IL-4 receptor [28].
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m836*m23257*0.1
nodelay
--
0
PMID: 10534111, 8663118 A second IL-13-specific receptor chain, IL-13Ra2, has been cloned from a human renal carcinoma cell line and binds IL-13 with much higher affinity [29].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m19*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m6*m1368*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m1639*m25*0.1
nodelay
--
0
PMID: 10534111 IFN-gamma binds its corresponding receptor.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m88*m81*0.1
nodelay
--
0
PMID: 10534111 GM-CSF binds its corresponding receptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c21 : 1
stoichiometry:c8 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 9558115, 10427971, 9558115, 10427971 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level. Furthermore, in kinetic studies of mRNA levels for gc and IL-13Ra1 with increasing time of culture for monocytes, as mRNA levels were reduced so too was the ability of IL-4 and IL-13 to suppress LPS-induced TNF-a production [16, 17].
p20
p20
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m2103*m2108*0.1
nodelay
--
0
PMID: 10534111 IL-10 binds its corresponding receptor.
p21
p21
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m1633*m26*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p21
p22
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m27*m1633*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
p21
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m1633*m28*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 The loss of IL-4- and IL-13-induced STAT6 activation with monocyte differentiation was unique because STATs activated by IFN-g, GM-CSF, and IL-10 were not altered with monocyte culture [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 9558115, 10427971 Furthermore, in kinetic studies of mRNA levels for gc and IL-13Ra1 with increasing time of culture for monocytes, as mRNA levels were reduced so too was the ability of IL-4 and IL-13 to suppress LPS-induced TNF-a production [16, 17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c74 : 1
m26*0.1
nodelay
--
0
PMID: 10534111, 10227996 It was recently shown that IL-4 could regulate TNF-a and IL-12 production by IFN-g-activated murine bone marrow-derived macrophages from STAT6-/- mice [31].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c79 : 1
stoichiometry:c78 : 1
m26*0.1
nodelay
--
0
PMID: 10534111, 10227996 It was recently shown that IL-4 could regulate TNF-a and IL-12 production by IFN-g-activated murine bone marrow-derived macrophages from STAT6-/- mice [31].
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c93 : 1
stoichiometry:c83 : 1
m11*0.1
nodelay
--
0
PMID: 10534111 First, a neutralizing antibody to gc blocked IL-4 regulation of LPSinduced TNF-a, but not IL-1b, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m32*m1951*0.1
nodelay
--
0
PMID: 10534111 Second, a mutant IL-4 molecule that was able to bind the IL-4Ra chain but not gc suppressed LPS-induced monocyte IL-1b, but not TNF-a, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m11*0.1
nodelay
--
0
PMID: 10534111 Second, a mutant IL-4 molecule that was able to bind the IL-4Ra chain but not gc suppressed LPS-induced monocyte IL-1b, but not TNF-a, production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c23 : 1
stoichiometry:c9 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
stoichiometry:c90 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 10427971 From studies using an antibody to the IL-4Ra chain, we know that this chain is a component of the receptor by which IL-4 and IL-13 signal suppression of LPS-induced IL-1b production by MDMac [17].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c95 : 1
stoichiometry:c94 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 9558115, 10427971, 9558115, 10427971 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c24 : 1
stoichiometry:c10 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c22 : 1
stoichiometry:c82 : 1
m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m1947*m1951*0.1
nodelay
--
0
PMID: 10534111, 9573026 It is believed that a site within the A/C helices of IL-4 first binds the IL-4Ra chain with high affinity. A site located near the end of helix D then binds gc, creating an active receptor dimer; mutations of the tyrosine at position 124 greatly reduces this interaction. There is strong evidence particularly on non-hematopoietic cells that the IL-4Ra chain on binding to IL-4 can heterodimerize with the IL-13Ra1 chain forming the type II IL-4 receptor [28].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m12691*m5*0.1
nodelay
--
0
PMID: 10534111 It is believed that a site within the A/C helices of IL-4 first binds the IL-4Ra chain with high affinity. A site located near the end of helix D then binds gc, creating an active receptor dimer; mutations of the tyrosine at position 124 greatly reduces this interaction.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
m5*m2081*0.1
nodelay
--
0
PMID: 10534111, 7843245 Western blots of gc on monocytes suggested proteins of 58 and 64 kDa but only the 64 kDa protein could associate with the IL-2Rb chain [23].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c49 : 1
stoichiometry:c27 : 1
m13*m11*0.1
nodelay
--
0
PMID: 10534111, 2786204, 2120129, 2785566, 2114443 IL-4 inhibited the production of lipopolysaccharide (LPS)-stimulated tumor necrosis factor a (TNF-a), IL-1b, IL-6, IL-10, and prostaglandin E2 (PGE2) [1?4] by monocytes and this regulation occurred for the peptides, at least in part, at the mRNA level.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--